Real-world evidence and nonrandomized data in health technology assessment: using existing methods to address unmeasured confounding?

Author:

Sammon Cormac J1,Leahy Thomas P1,Gsteiger Sandro2,Ramagopalan Sreeram2

Affiliation:

1. PHMR LTD, London, UK

2. F. Hoffmann-La Roche Ltd, Basel, Switzerland

Funder

F. Hoffmann-La Roche

Publisher

Future Medicine Ltd

Subject

Health Policy

Reference22 articles.

1. Faria R, Hernadez Alava M, Manca A, Wailoo A. The use of observational data to inform estimates of treatment effectiveness in technology appraisal: methods for comparative individual patient data. (2015). NICE Decision Support Unit, Technical Support Document 17. http://nicedsu.org.uk/technical-support-documents/observational-data-tsd/

2. Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal

3. Institute for Quality and Efficiency in Health Care. General methods (2015). https://www.iqwig.de/en/methods/methods-paper.3020.html

4. Indirekte Vergleiche in der frühen Nutzenbewertung in Deutschland – Erfahrungen aus den ersten 5 Jahren

5. Health Information and Quality Authority. Guidelines for evaluating the clinical effectiveness of health technologies in Ireland (2019). https://www.hiqa.ie/reports-and-publications/health-technology-assessment/guidelines-evaluating-clinical-effectiveness

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3